5 research outputs found

    Clinical Outcomes Following Treatment of Non-contained Intrabony Defects with Enamel Matrix Derivative (EMD) or Guided Tissue Regeneration (GTR). A 12-month Randomized Controlled Clinical trial

    No full text
    The purpose of this study is to compare the healing of deep, non-contained intrabony defects (i.e., with a ?80% 1-wall component and a residual 2- to 3-wall component in the most apical part) treated with either an enamel matrix derivative (EMD) or guided tissue regeneration (GTR) after 12 months

    Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization

    No full text
    Non

    Assessment of neurological manifestations in hospitalized patients with COVID‐19

    No full text
    corecore